BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7735089)

  • 1. Case management within a methadone maintenance program. A research demonstration project for HIV risk reduction.
    Hasson AL; Grella CE; Rawson R; Anglin MD
    J Case Manag; 1994; 3(4):167-72. PubMed ID: 7735089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case management of substance abusers with HIV disease.
    Schwartz B; Dilley J; Sorensen JL
    J Case Manag; 1994; 3(4):173-8. PubMed ID: 7735090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case management to enhance HIV risk reduction among users of injection drugs and crack cocaine.
    Falck R; Carlson RG; Price SK; Turner JA
    J Case Manag; 1994; 3(4):162-6. PubMed ID: 7735088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
    Hartel DM; Schoenbaum EE
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.
    Avants SK; Margolin A; Usubiaga MH; Doebrick C
    J Subst Abuse Treat; 2004 Mar; 26(2):67-78. PubMed ID: 15050083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of HIV testing and high-risk behaviors among clients in methadone maintenance treatment.
    Grella CE; Campos M; Anglin MD
    AIDS Educ Prev; 1998 Oct; 10(5):403-16. PubMed ID: 9799937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
    Gelkopf M; Weizman T; Melamed Y; Adelson M; Bleich A
    Isr J Psychiatry Relat Sci; 2006; 43(2):126-36. PubMed ID: 16910375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug czar seeks new emphasis on methadone treatment.
    AIDS Policy Law; 1997 Oct; 12(20):7. PubMed ID: 11364789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term, medically supervised, drug-free treatment and methadone maintenance treatment on drug users' emergency department use and hospitalization.
    Turner BJ; Laine C; Yang CP; Hauck WW
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S457-63. PubMed ID: 14648464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of HIV infection in the methadone program. A study of a drop-in clinic in Zurich].
    Huber-Stemich F; Haas H
    Schweiz Rundsch Med Prax; 1990 Sep; 79(36):1017-21. PubMed ID: 2218224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriateness of assertive case management for drug-involved prison releasees.
    Inciardi JA; Martin SS; Scarpitti FR
    J Case Manag; 1994; 3(4):145-9. PubMed ID: 7735085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing methadone medical maintenance in community-based clinics: disseminating evidence-based treatment.
    King VL; Burke C; Stoller KB; Neufeld KJ; Peirce J; Kolodner K; Kidorf M; Brooner RK
    J Subst Abuse Treat; 2008 Oct; 35(3):312-21. PubMed ID: 18294805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV.
    Drucker E; Lurie P; Wodak A; Alcabes P
    AIDS; 1998; 12 Suppl A():S217-30. PubMed ID: 9633006
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized trial of drug abuse treatment-linkage strategies.
    Sorensen JL; Masson CL; Delucchi K; Sporer K; Barnett PG; Mitsuishi F; Lin C; Song Y; Chen T; Hall SM
    J Consult Clin Psychol; 2005 Dec; 73(6):1026-35. PubMed ID: 16392976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of methadone maintenance.
    Barnett PG; Hui SS
    Mt Sinai J Med; 2000; 67(5-6):365-74. PubMed ID: 11064486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
    Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
    Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical issues in the application of case management to substance abuse treatment.
    Ridgely MS
    J Case Manag; 1994; 3(4):132-8. PubMed ID: 7735083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.